349 related articles for article (PubMed ID: 16988275)
1. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.
Dahlbäck M; Rask TS; Andersen PH; Nielsen MA; Ndam NT; Resende M; Turner L; Deloron P; Hviid L; Lund O; Pedersen AG; Theander TG; Salanti A
PLoS Pathog; 2006 Nov; 2(11):e124. PubMed ID: 17112315
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates.
Gamain B; Smith JD; Avril M; Baruch DI; Scherf A; Gysin J; Miller LH
Mol Microbiol; 2004 Jul; 53(2):445-55. PubMed ID: 15228526
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
Gill J; Chitnis CE; Sharma A
Malar J; 2009 Apr; 8():67. PubMed ID: 19374733
[TBL] [Abstract][Full Text] [Related]
7. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
[TBL] [Abstract][Full Text] [Related]
9. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
[TBL] [Abstract][Full Text] [Related]
10. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
11. Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.
Lekana Douki JB; Traore B; Costa FT; Fusaï T; Pouvelle B; Sterkers Y; Scherf A; Gysin J
Blood; 2002 Aug; 100(4):1478-83. PubMed ID: 12149234
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
[TBL] [Abstract][Full Text] [Related]
13. Designing a VAR2CSA-based vaccine to prevent placental malaria.
Fried M; Duffy PE
Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
[TBL] [Abstract][Full Text] [Related]
14. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
[TBL] [Abstract][Full Text] [Related]
15. The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies.
Khattab A; Chia YS; May J; Le Hesran JY; Deloron P; Klinkert MQ
Parasitol Res; 2007 Aug; 101(3):767-74. PubMed ID: 17525854
[TBL] [Abstract][Full Text] [Related]
16. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.
Avril M; Kulasekara BR; Gose SO; Rowe C; Dahlbäck M; Duffy PE; Fried M; Salanti A; Misher L; Narum DL; Smith JD
Infect Immun; 2008 Apr; 76(4):1791-800. PubMed ID: 18250177
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
[TBL] [Abstract][Full Text] [Related]
18. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
[TBL] [Abstract][Full Text] [Related]
19. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.
Fernandez P; Viebig NK; Dechavanne S; Lépolard C; Gysin J; Scherf A; Gamain B
Malar J; 2008 Sep; 7():170. PubMed ID: 18771584
[TBL] [Abstract][Full Text] [Related]
20. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
Elife; 2022 Feb; 11():. PubMed ID: 35103596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
